Safety and effectiveness of short-course AmBisome in the treatment of Post-Kala-azar Dermal Leishmaniasis (PKDL): a prospective cohort study in Bangladesh

Hdl Handle:
http://hdl.handle.net/10144/619115
Title:
Safety and effectiveness of short-course AmBisome in the treatment of Post-Kala-azar Dermal Leishmaniasis (PKDL): a prospective cohort study in Bangladesh
Authors:
den Boer, M; Das, Asish K; Akhter, F; Burza, S; Ramesh, V; Ahmed, BN; Zijlstra, EE; Ritmeijer, K
Journal:
Clinical Infectious Diseases
Abstract:
A safe and effective short-course treatment regimen for Post Kala Azar Dermal Leishmaniasis (PKDL) is considered essential for achieving and sustaining elimination of visceral leishmaniasis (VL) in the Indian subcontinent.(1, 2) Here, single dose liposomal amphotericin B (AmBisome) has been adopted as a first line regimen for VL; however the effectiveness and safety of AmBisome for PKDL has not been formally evaluated.
Publisher:
Oxford University Press
Issue Date:
15-Mar-2018
URI:
http://hdl.handle.net/10144/619115
DOI:
10.1093/cid/ciy172
PubMed ID:
29554244
Submitted date:
2018-05-03
Language:
en
ISSN:
1537-6591
Appears in Collections:
Leishmaniasis/Kala Azar

Full metadata record

DC FieldValue Language
dc.contributor.authorden Boer, Men
dc.contributor.authorDas, Asish Ken
dc.contributor.authorAkhter, Fen
dc.contributor.authorBurza, Sen
dc.contributor.authorRamesh, Ven
dc.contributor.authorAhmed, BNen
dc.contributor.authorZijlstra, EEen
dc.contributor.authorRitmeijer, Ken
dc.date.accessioned2018-05-08T14:16:36Z-
dc.date.available2018-05-08T14:16:36Z-
dc.date.issued2018-03-15-
dc.date.submitted2018-05-03-
dc.identifier.citationSafety and effectiveness of short-course AmBisome in the treatment of Post-Kala-azar Dermal Leishmaniasis (PKDL): a prospective cohort study in Bangladesh. 2018 Clin. Infect. Dis.en
dc.identifier.issn1537-6591-
dc.identifier.pmid29554244-
dc.identifier.doi10.1093/cid/ciy172-
dc.identifier.urihttp://hdl.handle.net/10144/619115-
dc.description.abstractA safe and effective short-course treatment regimen for Post Kala Azar Dermal Leishmaniasis (PKDL) is considered essential for achieving and sustaining elimination of visceral leishmaniasis (VL) in the Indian subcontinent.(1, 2) Here, single dose liposomal amphotericin B (AmBisome) has been adopted as a first line regimen for VL; however the effectiveness and safety of AmBisome for PKDL has not been formally evaluated.en
dc.language.isoenen
dc.publisherOxford University Pressen
dc.rightsArchived with thanks to Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of Americaen
dc.titleSafety and effectiveness of short-course AmBisome in the treatment of Post-Kala-azar Dermal Leishmaniasis (PKDL): a prospective cohort study in Bangladeshen
dc.identifier.journalClinical Infectious Diseasesen

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.